Concord Biotech

Concord Biotech
Public
IndustryBiotechnology
Founded2000
FounderSudhir vaid
Headquarters,
Area served
Worldwide
Key people
Sudhir Vaid
(Chairman & MD)

Ankur Vaid
(CEO)

ProductsBiologics
Small Molecules
Active ingredient
RevenueIncrease 247.95 crore (US$36 million) (2014–15)[1]
Websitewww.concordbiotech.com

Concord Biotech Limited (CBL) is a Biotechnology company headquartered in Ahmedabad, India. The Company manufactures fermentation based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide. Company manufacturing facility in Ahmedabad, India is approved by global regulatory bodies including US -Food and Drug Administration and EU-Good manufacturing practice.[2]

History

Concord founded in the year 2000 by Sudhir Vaid. From a single product company in 2000s, Concord today manufactures over 30 products across niche therapies such as immunosuppressant, oncology, antifungal and antibacterial.[3] Concord Biotech is the first company in India and the second in the world to develop an anti-immuno suppressant tachrolimus.[4] Quadria Capital, invested Rs 475.31 crore for a 20% stake in Concord Biotech Ltd. in 2016.[5][6][7] Rakesh Jhunjhunwala holds 30% stake in Concord.[8][9][10]

See also

References